Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aimei Health Technology (AFJK) EPS (Weighted Average and Diluted) (2024 - 2025)

Aimei Health Technology (AFJK) has 2 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.06 in Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 25.0% to $0.06 in Q3 2025 year-over-year; TTM through Sep 2025 was $0.21, a 78.82% decrease, with the full-year FY2024 number at $0.28, up 250.0% from a year prior.
  • EPS (Weighted Average and Diluted) reached $0.06 in Q3 2025 per AFJK's latest filing, down from $0.07 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for AFJK hit a ceiling of $0.08 in Q1 2024 and a floor of $0.03 in Q1 2025.